Profile of JTE-522 as a human cyclooxygenase-2 inhibitor

Japanese Journal of Pharmacology

Volumn 78, Issue 3, 1998, Pages 365-371

  Wakitani, Korekiyo ^a   Nanayama, Toyomichi ^a   Masaki, Michiko ^a   Matsushita, Mutsuyoshi ^a  

^a JAPAN TOBACCO INC   (Japan)

Author keywords

Cyclooxygenase; Cyclooxygenase 1; Cyclooxygenase 2; JTE 522; Non steroidal anti inflammatory drug (NSAID)

Indexed keywords

CALCIMYCIN; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; THROMBOXANE B2; TILMACOXIB; UNCLASSIFIED DRUG;

ARTICLE; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; THROMBOCYTE;

EID: 0031762180     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.78.365     Document Type: Article

References (29)

1. Xie W, Chipman JG, Robertson DL, Erikson RL and Simmons DL: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88, 2692-2696 (1991)
2. DeWitt DL: Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta 1083, 121-134 (1991)
3. Kujubu DA, Fletcher BS, Varnum BC, Lim RW and Herschman HR: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266, 12866-12872 (1991)
4. Hla T and Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89, 7384-7388 (1992)
5. Hempel SL, Monick MM and Hunninghake GW: Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 93, 391-396 (1994)
6. Xie W, Robertson DL and Simmons DL: Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs. Drug Dev Res 25, 249-265 (1992)
7. Smith WL and Marnett LJ: Prostaglandin endoperoxide synthases. Metal Ions Biol Syst 30, 163-199 (1994)
8. Kennedy BP, Chan CC, Culp SA and Cromlish WA: Cloning and expression of rat prostaglandin endoperoxide synthase (cyclooxygenase)-2 cDNA. Biochem Biophys Res Commun 197, 494-500 (1993)
9. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC and Seibert K: Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91, 3228-3232 (1994)
10. Harada Y, Hatanaka K, Saito M, Majima M, Ogino M, Kawamura M, Ohno T, Yang Q, Katori M and Yamamoto S: Detection of inducible prostaglandin H synthase-2 in cells in the exudate of rat carrageenin-induced pleurisy. Biomed Res 15, 127-130 (1994)
11. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231, 232-235 (1971)
12. Vane J: Towards a better aspirin. Nature 367, 215-216 (1994)
13. Rome LH and Lands WEM: Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by antiinflammatory drugs. Proc Natl Acad Sci USA 72, 4863-4865 (1975)
14. Kulamacz RJ and Lands WEM: Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents. J Biol Chem 260, 12572-12578 (1985)
15. Matsushita M, Masaki M, Yagi Y, Tanaka T and Wakitani K: Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats. Inflamm Res 46, 461-466 (1997)
16. Hammarström S and Falardeau P: Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets. Proc Natl Acad Sci USA 74, 3691-3695 (1977)
17. Nanayama T, Hara S, Inoue H, Yokoyama C and Tanabe T: Regulation of two isozymes of prostaglandin endoperoxide synthase and thromboxane synthase in human monoblastoid cell line U937. Prostaglandins 49, 371-382 (1995)
18. Ihara H, Yokoyama C, Miyata A, Kosaka T, Nüsing R, Ullrich V and Tanabe T: Induction of thromboxane synthase and prostaglandin endoperoxide synthase mRNAs in human erythroleukemia cells by phorbol ester. FEBS Lett 306, 161-164 (1992)
19. Reddy RG, Yoshimoto T, Yamamoto S and Marnett LJ: Expression, purification, and characterization of porcine leucocyte 12-lipoxygenase produced in the methylotrophic yeast, Pichia pastoris. Biochem Biophys Res Commun 205, 381-388 (1994)
20. Takahashi Y, Reddy GR, Ueda N, Yamamoto S and Arase S: Arachidonate 12-lipoxygenase of platelet-type in human epidermal cells. J Biol Chem 268, 16443-16448 (1993)
21. Riendeau D, Charleson S, Cromlish W, Mancini JA, Wong E and Guay J: Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharmacol 75, 1088-1095 (1997)
22. Patrignani P, Panara MR, Greco A, Fusco O, Natoli C, Iacobelli S, Cipollone F, Ganci A, Créminon C, Maclouf J and Patrono C: Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 271, 1705-1712 (1994)
23. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC and Seibert K: Expression and selective inhibition of the constitutive and inducible forms of human cyclooxygenase. Biochem J 305, 479-484 (1995)
24. Huff R, Collins P, Kramer S, Seibert K, Koboldt C, Gregory S and Isakson P: A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl]methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2). Inflamm Res 44, 5145-5146 (1995)
25. Quellet M and Percival MD: Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms. Biochem J 306, 247-251 (1995)
26. 523 → Val mutation. J Biol Chem 272, 9280-9286 (1997)
27. Morita I, Schindler M, Regier MK, Otto JC, Hori T, DeWitt DL and Smith WL: Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 270, 10902-10908 (1995)
28. Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret J-P, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Leger S, Mancini JA, O'Neill G, Quellet M, Rodger Iw, Therien M, Wang Z, Webb JK, Wong E, Xu L, Young RN, Zamboni R, Prasit P and Chan C-C: Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 121, 105-117 (1997)
29. Masaki M, Matsushita M and Wakitani K: Inhibitory effects of JTE-522, a novel prostaglandin H synthase-2 inhibitor, on adjuvant-induced arthritis and bone changes in rats. Inflamm Res 47, 187-192 (1998)